[2][5] PAL-GHK is often used in research studies to examine how peptides interact with cells
Despite their success, access to incretin peptide analogues is challenging for most individuals that require these therapies due to their high cost and complex manufacturing process leading to supply shortages, as well as requirement for refrigeration and administration by injection, together with notable side effects including gastrointestinal disturbances, prompting further research into the development of a new wave of small molecules (8, 9), including those targeting the receptor as allosteric or ago-allosteric modulators (10, 11)
Similar results were observed when tumours were implanted into the flanks of mice, a result that suggests that this phenotype is not specific to the mammary gland environment (Extended Data Fig
Recovery speed improvements typically show up in weeks three to four
Women also face specific considerations around gallbladder disease risk, potential effects on bone density, and interactions with oral hormonal contraceptives
